BroadOak Capital Partners advised KCAS Bioanalytical and Biomarker Services ("KCAS") on the sale of the company to Vitruvian. KCAS is a leading contract research organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and animal health industries.
The full press release is below.
Vitruvian Partners announces strategic growth investment in KCAS Bioanalytical and Biomarker Services
Vitruvian's acquisition enables KCAS to further accelerate global growth both through acquisitions and expansion of its U.S. operations
LONDON–(BUSINESS WIRE)–Vitruvian Partners announced it has acquired a majority ownership stake in KCAS, located in the Kansas City, Kansas metropolitan area. Management and current majority shareholders KVCI made significant reinvestments in the company. Other financial terms were not disclosed.
KCAS is a U.S.-based Contract Research Organization providing comprehensive GLP-compliant bioanalytical and biomarker development testing services for the biotech, pharmaceutical, and animal health industries. The company offers bioanalytical services from early discovery through registration, covering biological and synthetic drug candidates. Vitruvian's investment supports KCAS expansion in Kansas City with a 70,000 sq ft facility, scientific talent recruitment, and international growth through acquisitions.
John Bucksath, CEO of KCAS, stated: "We are delighted working with Vitruvian to advance organic and inorganic growth plans supporting increased service demand."
Sophie Bower-Straziota, Partner at Vitruvian Partners, commented: "KCAS has built a strong reputation in bioanalytical services under excellent leadership and will benefit from our investment strategy."
Brian Lueger, Konza Valley Capital Inc., noted: "We are excited to continue investing alongside Vitruvian Partners."
Vitruvian was advised by William Blair, Kirkland & Ellis LLP, FTI Consulting, Bain Consulting and PwC. KVCI and KCAS were advised by BroadOak Capital and Polsinelli.